CLINICAL_TRIALS
research
· 2017-03-03
Clinical Trial Update: Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury [Phase 4]
Summary
Phase 4 clinical trial update aiming to identify predictive risk factors for chemotherapy-induced drug-induced liver injury.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Liver Injury, Drug-Induced | Phase 4 | Status: UNKNOWN